• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    S&P 500 Closes At Record High Ahead Of Inflation Data: Fear & Greed Index Remains In 'Neutral' Zone

    7/9/24 3:27:30 AM ET
    $C
    $DAL
    $HELE
    $JPM
    Major Banks
    Finance
    Air Freight/Delivery Services
    Consumer Discretionary
    Get the next $C alert in real time by email

    The CNN Money Fear and Greed index showed a slight decline in the overall market sentiment, while the index remained in the “Neutral” zone on Monday.

    U.S. stocks closed mixed on Monday, with the S&P 500 closing at a record high during the session.

    All three major indices closed higher last week, with the Nasdaq Composite jumping 3.5%, and the S&P 500 adding around 2%. The Dow, meanwhile, added around 0.7% last week.

    Data on consumer price index for June will be released on Thursday, while producer price index data will be released on Friday.

    Eli Lilly And Co (NYSE:LLY) agreed to acquire Morphic Holding Inc (NASDAQ:MORF) for $57 per share in cash, an aggregate of approximately $3.2 billion.

    Most sectors on the S&P 500 closed on a negative note, with communication services, consumer staples, and energy stocks recording the biggest losses on Monday. However, information technology and materials stocks bucked the overall market trend, closing the session higher.

    The Dow Jones closed lower by around 31 points to 39,344.79 on Monday. The S&P 500 rose 0.10% at 5,572.85, while the Nasdaq Composite climbed 0.28% at 18,403.74 during Monday's session.

    Investors are awaiting earnings results from Helen of Troy Limited (NASDAQ:HELE), SMART Global Holdings, Inc. (NASDAQ:SGH) and Kura Sushi USA, Inc. (NASDAQ:KRUS) today.

    PepsiCo (NASDAQ:PEP) and Delta Air Lines (NYSE:DAL) will release earnings results on Thursday, while Citigroup (NYSE:C) and JPMorgan Chase (NYSE:JPM) are scheduled to report second-quarter earnings on Friday.

    What is CNN Business Fear & Greed Index?

    At a current reading of 52.69, the index remained in the “Neutral” zone on Monday, versus a prior reading of 52.74.

    The Fear & Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.

    Read Next:

    • PepsiCo Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
    Get the next $C alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $C
    $DAL
    $HELE
    $JPM

    CompanyDatePrice TargetRatingAnalyst
    JP Morgan Chase & Co.
    $JPM
    3/26/2026$310.00Hold
    Jefferies
    Citigroup Inc.
    $C
    3/26/2026$135.00Buy
    Jefferies
    Eli Lilly and Company
    $LLY
    3/17/2026$850.00Hold → Reduce
    HSBC Securities
    Kura Sushi USA Inc.
    $KRUS
    3/6/2026$90.00Buy
    DA Davidson
    Eli Lilly and Company
    $LLY
    2/25/2026$1250.00Outperform
    RBC Capital Mkts
    Eli Lilly and Company
    $LLY
    2/20/2026$1350.00Overweight
    Barclays
    JP Morgan Chase & Co.
    $JPM
    2/3/2026$280.00Underperform → Neutral
    Robert W. Baird
    PepsiCo Inc.
    $PEP
    1/16/2026$179.00Neutral → Outperform
    BNP Paribas Exane
    More analyst ratings

    $C
    $DAL
    $HELE
    $JPM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & CFO Montarce Lucas bought $494,627 worth of shares (715 units at $691.79), increasing direct ownership by 5% to 14,685 units (SEC Form 4)

    4 - ELI LILLY & Co (0000059478) (Issuer)

    8/15/25 4:13:02 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Alvarez Ralph bought $500,473 worth of shares (758 units at $660.25) (SEC Form 4)

    4 - ELI LILLY & Co (0000059478) (Issuer)

    8/14/25 4:12:51 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP & Pres., Lilly Oncology Van Naarden Jacob bought $647,360 worth of shares (1,000 units at $647.36), increasing direct ownership by 5% to 20,562 units (SEC Form 4)

    4 - ELI LILLY & Co (0000059478) (Issuer)

    8/13/25 4:15:45 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $C
    $DAL
    $HELE
    $JPM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions

    Adults taking Foundayo lost an average of 27 pounds on the highest dose in the ATTAIN-1 clinical trial1Foundayo, Lilly's second FDA-approved obesity medicine, will be available via LillyDirect® with free home delivery, starting at $25 per month with commercial coverage and $149 for self-payINDIANAPOLIS, April 1, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for adults with obesity, or overweight with weight-related medical problems. When used alongside a reduced-calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo

    4/1/26 11:30:00 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Georgia Cleantech Innovation Hub Awarded $600,000 by JPMorganChase to Strengthen Atlanta's Clean Tech Talent and Startup Ecosystem

    Two-Year Grant Funds Experiential Learning at Atlanta Universities and Planning for the City's First Build‑and‑Test Space for Clean Tech Startups ATLANTA, April 1, 2026 /PRNewswire/ -- Today, Georgia Cleantech Innovation Hub announced a new initiative with support from JPMorganChase, including a $600,000 philanthropic commitment to the Georgia Cleantech Innovation Hub (GACIH) to build the workforce and infrastructure needed to grow and scale clean technologies and businesses that save energy and water, cut waste, improve efficiency and reduce pollution—creating new opportunities for innovation, skilled jobs, and long‑term cost savings across the economy

    4/1/26 6:00:00 AM ET
    $JPM
    Major Banks
    Finance

    J.P. Morgan Private Capital Expands Team with Senior Hires

    Rand Araskog joins as Partner from PermiraEric Ghernati transitions to Partner role from J.P. Morgan Asset Management U.S. Equity GroupNEW YORK, March 31, 2026 /PRNewswire/ -- J.P. Morgan Private Capital, the venture and growth equity investment arm within J.P. Morgan Asset Management, today announced the appointments of Rand Araskog and Eric Ghernati as Partners focused on investing in leading growth companies. The team's expansion comes in response to a fundamental shift in capital markets. Companies are staying private for longer, with the median age at IPO of U.S. tech compa

    3/31/26 8:30:00 AM ET
    $JPM
    Major Banks
    Finance

    $C
    $DAL
    $HELE
    $JPM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies initiated coverage on JPMorgan Chase with a new price target

    Jefferies initiated coverage of JPMorgan Chase with a rating of Hold and set a new price target of $310.00

    3/26/26 8:49:56 AM ET
    $JPM
    Major Banks
    Finance

    Jefferies initiated coverage on Citigroup with a new price target

    Jefferies initiated coverage of Citigroup with a rating of Buy and set a new price target of $135.00

    3/26/26 8:47:49 AM ET
    $C
    Major Banks
    Finance

    Eli Lilly downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Eli Lilly from Hold to Reduce and set a new price target of $850.00

    3/17/26 7:55:56 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $C
    $DAL
    $HELE
    $JPM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    May 31, 2024 - FDA Roundup: May 31, 2024

    For Immediate Release: May 31, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. mRESVIA is an mRNA-based vaccine that is manufa

    5/31/24 3:22:42 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 7, 2024 - FDA Roundup: May 7, 2024

    For Immediate Release: May 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for midomafetamine (MDMA) capsules, submitted by Lykos Therapeutics, for the treatment of post-traumatic stress disorder. The committ

    5/7/24 4:10:24 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    December 5, 2023 - FDA Roundup: December 5, 2023

    For Immediate Release: December 05, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, registration opened for the FDA’s virtual Rare Disease Day on Friday, March 1, 2024. This year’s Rare Disease Day is dedicated to patients and health care professionals. Panels will discuss efforts to address the unique challenges with developing treat

    12/5/23 5:00:21 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $C
    $DAL
    $HELE
    $JPM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Novakovic Phebe N

    4 - JPMORGAN CHASE & CO (0000019617) (Issuer)

    4/1/26 4:16:52 PM ET
    $JPM
    Major Banks
    Finance

    SEC Form 4 filed by Rometty Virginia M

    4 - JPMORGAN CHASE & CO (0000019617) (Issuer)

    4/1/26 4:16:54 PM ET
    $JPM
    Major Banks
    Finance

    SEC Form 4 filed by Burke Stephen B

    4 - JPMORGAN CHASE & CO (0000019617) (Issuer)

    4/1/26 4:16:49 PM ET
    $JPM
    Major Banks
    Finance

    $C
    $DAL
    $HELE
    $JPM
    Financials

    Live finance-specific insights

    View All

    J.P. Morgan Debuts Equity Premium Yield ETFs ROCY and ROCQ on Nasdaq

    New Active ETFs Expand Innovative Derivative Income Suite NEW YORK, March 19, 2026 /PRNewswire/ -- J.P. Morgan Asset Management today announced the launch of two new active ETFs on the Nasdaq Exchange as part of the firm's landmark derivative income suite, the JPMorgan Equity Premium Yield ETF (ROCY) and the JPMorgan Nasdaq Equity Premium Yield ETF (ROCQ). With the introduction of ROCY and ROCQ, J.P. Morgan is now the only ETF provider offering a comprehensive suite of actively managed derivative income strategies, with three distinct methods of treating options premium.Led by H

    3/19/26 12:30:00 PM ET
    $JPM
    Major Banks
    Finance

    Delta Air Lines Announces Webcast of March Quarter 2026 Financial Results

    ATLANTA, March 19, 2026 /PRNewswire/ -- Delta Air Lines (NYSE:DAL) will hold a live conference call and webcast to discuss its March quarter 2026 financial results at 10 a.m. ET, Wednesday, April 8, 2026. A live webcast of this event will be available at ir.delta.com and an online replay will be available shortly after the webcast is complete.About Delta Air LinesNo one better connects the worldThrough exceptional service and the power of innovation, Delta Air Lines (NYSE:DAL) never stops looking for ways to make every trip feel tailored to every customer.    There are 100,000 D

    3/19/26 11:00:00 AM ET
    $DAL
    Air Freight/Delivery Services
    Consumer Discretionary

    JPMorganChase Declares Common Stock Dividend

    JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") declared a quarterly dividend on the outstanding shares of the common stock of JPMorganChase. Information can be found on the Firm's Investor Relations website at https://www.jpmorganchase.com/ir/news. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorganChase had $4.4 trillion in assets and $362 billion in stockholders' equity as of December 31, 2025. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under

    3/17/26 4:47:00 PM ET
    $JPM
    Major Banks
    Finance

    $C
    $DAL
    $HELE
    $JPM
    SEC Filings

    View All

    SEC Form FWP filed by JP Morgan Chase & Co.

    FWP - JPMORGAN CHASE & CO (0000019617) (Subject)

    4/2/26 9:31:45 AM ET
    $JPM
    Major Banks
    Finance

    SEC Form FWP filed by JP Morgan Chase & Co.

    FWP - JPMORGAN CHASE & CO (0000019617) (Subject)

    4/2/26 8:54:52 AM ET
    $JPM
    Major Banks
    Finance

    SEC Form FWP filed by JP Morgan Chase & Co.

    FWP - JPMORGAN CHASE & CO (0000019617) (Subject)

    4/2/26 6:24:55 AM ET
    $JPM
    Major Banks
    Finance

    $C
    $DAL
    $HELE
    $JPM
    Leadership Updates

    Live Leadership Updates

    View All

    JPMorganChase Partners With Sports Legends to Help Athletes Master Their Money

    Athlete Council to guide JPMorganChase in new programs for athletes JPMorganChase today announced a new initiative to help athletes navigate every aspect of their financial lives, from early career stages through retirement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260318551874/en/Names listed in photo order from left to right for each row. Building on the firm's extensive banking and wealth planning and management expertise, the JPMorganChase Athlete Council brings together some of the world's most accomplished sports figures who will meet with JPMorganChase leaders on a periodic basis to discuss the unique financial ne

    3/18/26 12:30:00 PM ET
    $JPM
    Major Banks
    Finance

    J.P. Morgan Asset Management Bolsters Commitment to Private Wealth Alternatives with Senior Hires

    Stephanie Davis joins as Head of Private Wealth Alternatives from Hamilton LaneSean Flynn tapped as Private Wealth Alternatives National Manager  NEW YORK, March 3, 2026 /PRNewswire/ -- J.P. Morgan Asset Management today announced the appointment of Stephanie Davis as Head of Private Wealth Alternatives, leading an increased focus on serving financial advisors across the U.S. Stephanie brings three decades of experience, most recently as Co-Head of U.S. Private Wealth Solutions at Hamilton Lane. Based in New York, she will report to Steve Lundquist, Head of U.S. Advisor. In her

    3/3/26 9:30:00 AM ET
    $JPM
    Major Banks
    Finance

    BlackRock Appoints Citi to Provide Select ETF Middle Office Services on Aladdin

    Key Highlights: BlackRock has selected Citi to provide select middle office services for $4.0 trillion in U.S. domiciled iShares ETFs on the Aladdin platform1 This partnership enhances ETF order transparency and streamlines processing, reinforcing Citi's expanded ETF and middle office servicing capabilities The collaboration follows a 2021 mandate where Citi was appointed as an additional post-trade service provider for BlackRock's U.S. domiciled ETFs BlackRock has appointed Citi Investor Services to provide select middle office functions for $4.0 trillion in U.S. domiciled iShares ETFs on the Aladdin platform. Expanding on the long-standing partnership between BlackRock and C

    2/26/26 9:00:00 AM ET
    $C
    Major Banks
    Finance

    $C
    $DAL
    $HELE
    $JPM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Citigroup Inc.

    SC 13D - CITIGROUP INC (0000831001) ()

    1/5/94 12:00:00 AM ET
    $C
    Major Banks
    Finance

    Amendment: SEC Form SC 13G/A filed by Helen of Troy Limited

    SC 13G/A - HELEN OF TROY LTD (0000916789) (Subject)

    11/14/24 3:53:05 PM ET
    $HELE
    Home Furnishings
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Helen of Troy Limited

    SC 13G/A - HELEN OF TROY LTD (0000916789) (Subject)

    11/12/24 3:49:29 PM ET
    $HELE
    Home Furnishings
    Consumer Discretionary